New biomarkers could mean earlier, more accurate mesothelioma diagnosis
from Surviving Mesothelioma
In what could be a breakthrough in the development of a reliable diagnostic test for mesothelioma, Danish scientists have identified what they say are four key biomarkers that distinguish the asbestos cancer from non-malignant conditions. If the new research from Copenhagen University can be validated, it may dramatically shorten the time it takes to identify mesothelioma and start aggressive therapies.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063